Saudi Arabia Hepatic Fibrosis Biomarkers Market Size & Outlook

The hepatic fibrosis biomarkers market in Saudi Arabia is expected to reach a projected revenue of US$ 13.1 million by 2033. A compound annual growth rate of 12.7% is expected of Saudi Arabia hepatic fibrosis biomarkers market from 2025 to 2033.
Revenue, 2024 (US$M)
$4.2
Forecast, 2033 (US$M)
$13.1
CAGR, 2025 - 2033
12.7%
Report Coverage
Saudi Arabia

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Saudi Arabia hepatic fibrosis biomarkers market, 2021-2033 (US$M)

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Saudi Arabia hepatic fibrosis biomarkers market highlights

  • The Saudi Arabia hepatic fibrosis biomarkers market generated a revenue of USD 4.2 million in 2024 and is expected to reach USD 13.1 million by 2033.
  • The Saudi Arabia market is expected to grow at a CAGR of 13.5% from 2025 to 2033.
  • In terms of segment, kits and assays was the largest revenue generating product in 2024.
  • Services is the most lucrative product segment registering the fastest growth during the forecast period.


Hepatic fibrosis biomarkers market data book summary

Market revenue in 2024USD 4.2 million
Market revenue in 2033USD 13.1 million
Growth rate13.5% (CAGR from 2025 to 2033)
Largest segmentKits and assays
Fastest growing segmentServices
Historical data2021 - 2023
Base year2024
Forecast period2025 - 2033
Quantitative unitsRevenue in USD million
Market segmentationKits and assays, Reagents, Services


Other key industry trends

  • In terms of revenue, Saudi Arabia accounted for 1.0% of the global hepatic fibrosis biomarkers market in 2024.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
  • In Middle East & Africa, Saudi Arabia hepatic fibrosis biomarkers market is projected to lead the regional market in terms of revenue in 2033.
  • UAE is the fastest growing regional market in Middle East & Africa and is projected to reach USD 9.3 million by 2033.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Hepatic Fibrosis Biomarkers Market Companies

Name Profile # Employees HQ Website
BioPredictive View profile 1-10 Paris, Ile-de-France, France, Europe https://www.biopredictive.com
Exalenz Bioscience View profile 11-50 Union, New Jersey, United States, North America http://www.exalenz.com/
Siemens Healthineers AG View profile - - -
Bristol-Myers Squibb Company View profile - - -
The Prometheus Group View profile 1-10 Dover, New Hampshire, United States, North America https://theprogrp.com
AstraZeneca View profile 10001+ Cambridge, Cambridgeshire, United Kingdom, Europe http://www.astrazeneca.com
Pfizer View profile 10001+ New York, New York, United States, North America http://www.pfizer.com
Genfit SA View profile 159 Parc Eurasante, 885, Avenue Eugene Avinee, Loos, France, 59120 https://www.genfit.com
Labcorp Holdings Inc View profile 67000 358 South Main Street, Burlington, NC, United States, 27215 https://www.labcorp.com
Quest Diagnostics Inc View profile 48000 500 Plaza Drive, Secaucus, NJ, United States, 07094 https://www.questdiagnostics.com

Saudi Arabia hepatic fibrosis biomarkers market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to hepatic fibrosis biomarkers market will help companies and investors design strategic landscapes.


Kits and assays was the largest segment with a revenue share of 47.62% in 2024. Horizon Databook has segmented the Saudi Arabia hepatic fibrosis biomarkers market based on kits and assays, reagents, services covering the revenue growth of each sub-segment from 2021 to 2033.


Reasons to subscribe to Saudi Arabia hepatic fibrosis biomarkers market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Saudi Arabia hepatic fibrosis biomarkers market databook

  • Our clientele includes a mix of hepatic fibrosis biomarkers market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the Saudi Arabia hepatic fibrosis biomarkers market , including forecasts for subscribers. This country databook contains high-level insights into Saudi Arabia hepatic fibrosis biomarkers market from 2021 to 2033, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Saudi Arabia hepatic fibrosis biomarkers market size, by product, 2021-2033 (US$M)

Saudi Arabia Hepatic Fibrosis Biomarkers Market Outlook Share, 2024 & 2033 (US$M)

Saudi Arabia hepatic fibrosis biomarkers market size, by product, 2021-2033 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more
Chat with us
Research Assistance
Online